Belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company, today announced that its annual report on Form 20-F, containing audited consolidated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback